Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2013

To view an abstract, select an author from the vertical list on the left.

2013 Grants - Ances

Resting State Network Signature of Alzheimer's Disease

Beau M. Ances, M.D. Ph.D.
Washington University in St. Louis
St. Louis, Missouri

2013 New Investigator Research Grant

A major goal of Alzheimer's research is the development of ways to accurately detect the disease in its earliest stages, before substantial brain damage occurs. One promising approach is the use of imaging to visualize brain structure or amyloid plaques, one of the characteristic features of the disease. Brain scans using a special type of magnetic resonance imaging (MRI) can also be used to visualize how signals from one part of the brain spread to other parts, forming what are called functional brain networks.

Beau M. Ances, M.D., Ph.D. and colleagues have proposed to use MRI to visualize functional networks in people at high risk for Alzheimer's disease to determine how that risk affects the activity of their brain networks. They plan to perform these imaging studies while the brain is "at rest," meaning the participants will not be given any particular brain stimulus, such as an image or spoken prompt. Dr. Ances and colleagues will characterize functional networks in the brain and determine how they change in people at high risk for Alzheimer's disease. They will also measure chemical markers of risk in each person's cerebrospinal fluid, the fluid that surrounds nerve cells in the brain and spinal column. This will allow the researchers to study how functional networks change as markers of disease increase. These studies may lead to the development of new and sensitive ways to detect the early stages of Alzheimer's disease using brain imaging.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.